Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.
<h4>Background</h4>Data on initiation and utilization of direct-acting antiviral therapies for hepatitis C virus infection in the United States are limited. This study evaluated treatment initiation, time to treatment, and real-world effectiveness of direct-acting antiviral therapy in in...
Main Authors: | Paul Y Kwo, Amy Puenpatom, Zuoyi Zhang, Siu L Hui, Andrea A Kelley, David Muschi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0218759 |
Similar Items
-
P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017-08-01) -
Real-World Results of Direct-Acting Antiviral Agents for Chronic Hepatitis C
by: Chun-Ming Hong, et al.
Published: (2018) -
Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda: A prospective cohort study
by: Dale A Barnhart, et al.
Published: (2021-01-01) -
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
by: Leah L. Zullig, et al.
Published: (2019-07-01) -
Retrospective Evaluation on Patient Screening and Counseling Service on Direct-acting Antivirals Against Hepatitis C
by: Bob Ka Him Wong, et al.
Published: (2020-05-01)